Cardiovascular Journal of Africa: Vol 23 No 8 (September 2012) - page 64

CARDIOVASCULAR JOURNAL OF AFRICA • Vol 23, No 8, September 2012 e6 AFRICA
immunodeficiency virus (HIV)-related heart disease: A review. Niger J
Med 2005; 14(3): 255–260.
8. Yunis NA, Stone VE . Cardiac manifestations of HIV/AIDS: A review
of disease spectrum and clinical management. J Acquir Immune Defic
Synd Hum Retrovirol 1998; 18: 145–154.
9. Nzuobontane D, Blackett KN , Kuaban C. Cardiac Involvement in
HIV infected people in Yaounde Cameroon. Postgrad Med J 2002; 78:
678–681.
10. Hecht SR, Berger M, VanTosh A, Croxson S. Unsuspected cardiac
abnormalities in the acquired immune deficiency syndrome: an echo-
cardiographic study. Chest 1989; 96: 805–808.
11. Milei J, Grana D, Fernandez A, Matturri L. Cardiac involvement in
Acquired Immune Deficiency Syndrome – a review to push action. Clin
Cardiol 1998; 21: 465–472.
12. Gottdiener JS, Bednarz J, Devereux R, Gardin J, Klein A, Manning
WJ, et al. American Society of Echocardiography recommendations for
use of echocardiography in clinical trials: A report from the American
Society of Echocardiography’s Guidelines and Standards Committee
and the Task Force on Echocardiography in Clinical Trials. J Am Soc
Echocardiogr 2004; 17: 1086–1119.
13. Feigenbaum H. Echocardiography. Philadelphia: Lippincott William
and Wilkins, 2005: 138–180.
14. Henry WL, De Maria A, Gramiak R, King DL, Kisslo IA, Popp
RL, Sahn DI. Report of the American Society of Echocardiography
committee on nomenclature and standards in 2-D echocardiography.
Circulation 1980; 62: 212–217.
15. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E,
Pellikka PA, et al. Recommendations for chamber quantification. Eur J
Echocardiogr 2006; 7: 79–108.
16. Longo-Mbenza B, Seghers L, Vita E, Tonduangu K, Bayekula M.
Assessment of ventricular diastolic function in AIDS patients from
Congo: a Doppler echocardiographic study. Heart 1998; 80: 184–189.
17. Chariot P, Perchert H, Monnet I. Dilated cardiomyopathy in HIV
patients. N Engl J Med 1999: 340: 732–735.
18. Longo-Mbenza B, Seghers KV, Phuati M, Bikangi FN, Mubagwa K.
Heart involvement and HIV infection in African patients: determinants
of survival. Int J Cardiol. 1998; 64(1): 63–73.
19. Currie PF, Jacob AJ, Foreman AR, Elton RA, Brettle RP, Boon NA.
Heart muscle disease related to HIV infection; prognostic implications.
Br Med J 1994; 390: 1605–1607.
20. Hakim JG, Matenga JA, Siziya S. Myocardial dysfunction in HIV
infection: an echocardiographic study of 157 patients in hospital in
Zimbabwe. Heart 1996: 76: 161–165.
21. Taylor D. Diastolic function, the necessary basics. J Diagnostic Med
Sonogr 2006; 22: 99–108.
22. Heidenreich PA , Eisenberg MJ, Kee LL, Somelofski CA, Hollander H,
Schiller NB, Cheitlin MD. Pericardial effusion in AIDS: incidence and
survival. Circulation 1995: 92: 3229–3234.
23. Silva-Cardoso J, Moura B , Martins L, Mota-Miranda. A, Rocha-
Goncalves F. Pericardial involvement in human immunodeficiency
virus infection. Chest 1999: 115: 418–422.
24. Okeahialam BN, Anjorin FL. Echocardiographic study of the heart in
AIDS. The Jos experience. Trop Card 2000; 26: 3–6.
25. Danbauchi SS, Sani SG, Alhassan MA, Oyati IA, Kwaifa SI, David SO,
Larif MS. Cardiac manifestations of stage III/IV HIV/AIDS compared
to subjects on ARV in Zaria, Nigeria. Nig J Cardiol 2006; 3: 5–10.
26. Currie, PF, Boon, NA. Human immunodeficiency virus infection and
the heart. In: McMurray JJV, Cleland JGF (eds). Heart Failure in
Clinical Practice. London: Martin Dunitz 1996; 2: 85–108.
27. Cegielski JP, Ramiya K ,Lallinger GJ, Mtulia IA, Mbaga IM. Pericardial
disease and human immunodeficiency virus in Dares Salaam, Tanzania.
Lancet 1990: 335: 209–212.
28. Corallo S, Mutinelli MR, Momoi M, Lazzarin A, Celano V, Repossini
A, Barold G. Echocardiography detects myocardial damage in AIDS:
prospective study in 102 patients. Eur Heart J 1988; 9: 887–892.
29. Ntsekhe M, Hakim J. Impact of human immunodeficiency virus
infection on cardiovascular disease in Africa. Circulation 2005; 112:
3602–3607.
30. Hoffmann C, Rockstroh JK, Kamps BS. HIV Medcine , 2007: 1–818.
http://hivmedicine.com/textbook/cr.htm.
31. Woods GL, Goldsmith JC. Fatal pericarditis due to Mycobacterium
avium-intracellulare in acquired immunodeficiency syndrome. Chest
1989: 95: 1355–1357.
32. Schuster M, Valentine F, Holzman R. Cryptococcal pericarditis in an
intravenous drug abuser. J Infect Dis 1985; 152: 842.
33. Karve MM, Murali MR, Shah HM, Phelps KR. Rapid evolution of
cardiac tamponade due to bacterial pericarditis in two patients with
HIV-1 infection. Chest 1992; 101: 1461–1463.
34. Barbaro G, Lorenzo G, Grisorio B, Barbarini G. Incidence of dilated
cardiomyopathy and detection of HIV in myocardial cells of HIV posi-
tive patients. N Engl J Med 1998; 339: 1093–1099.
35. Herskowitz A, Vlahov D, Willoughby S, Chaisson RE, Schulman
SP, Neumann DA, Baughman KL. Prevalence and Incidence of Left
Ventricular Dysfunction in Human Immunodeficiency Virus Infection.
Am J Cardiol 1993; 71: 955–958.
36. Blanchard DG, Hagenhoff C, Chow LC, McCann HA, Dittrich HC.
Reversibility of cardiac abnormalities in human immunodeficiency
virus (HIV)-infected individuals; a serial echocardiographic study. J Am
Coll Cardiol 1991; 17: 1270–1276.
37. Cardoso JS, Moura B, Martins L, Mota-Miranda A, Rocha Goncalves
F, Lecour H. Left ventricular dysfunction in HIV- infected patients. Int
J Cardiol 1998; 63: 37–45.
38. Werneck GL, Mesquita ET, Romêo FLJM, Ribeiro ML. Doppler echo-
cardiographic evaluation of HIV-positive patients in different stages of
the disease. Arq Bras Cardiol 1999; 73(2): 157–168.
39. Himelman R, Chung W, Chernoff N, Schiller NB, Hollander H. Cardiac
manisfestations of human immunodeficiency virus infection: a two
dimensional echocardiography study. J Am Coll Cardiol 1989; 13:
1030–1036.
40. Barbaro G, Di Lorenzo G, Soldini M, Giancaspro G, Grisorio B,
Pellicelli A, Barbarini G. The intensity of myocardial expression of
inducible nitric oxide synthase influences the clinical course of human
immunodeficiency virus-associated cardiomyopathy. Circulation 1999;
100: 633–639.
41. Lipshultz SE. Dilated cardiomyopathy in HIV-infected patients [edito-
rial]. N Engl J Med 1998; 339: 1153–1155.
42. Barbaro G, Fisher SD, Pellicelli AM, Liphultz SE. The expanding role
of the cardiologist in the care of HIV infected patients. Heart 200; 86:
365–367.
43. Calabrese LH, Proffitt MR, Yen-Lieberman B, Hobbs RE, Ratliff NB.
Congestive cardiomyopathy and illness related to the acquired immu-
nodeficiency syndrome (AIDS) associated with isolation of retrovirus
from myocardium. Ann Intern Med 1987; 107: 691–692.
44. Herskowitz A, Willoughby SB, Baughman KL, Schulman SP, Bartlett
JD. Cardiomyopathy associated with anti-retroviral therapy in patients
with human immunodeficiency virus infection: a report of six cases.
Ann Intern Med 1992; 116: 311–313.
45. Herskowitz A, Willoughby SB, Vlahov D, Baughman KL, Ansari AA.
Dilated heart muscle disease associated with HIV infection. Eur Heart
J 1995; 16(suppl O): 50–55.
46. Currie PF, Goldman JH, Caforio ALP, Jacob AJ, Baig MK, Brettle RP,
et al. Cardiac autoimmunity in HIV related heart muscle disease. Heart
1998; 79: 599–604.
47. Cardoso JS, Miranda AM, Moura B, Gomes MH, Oliveira P, Conde C,
et al. Cardiac morbidity in the human immunodeficiency virus infec-
tion. Rev Port Cardiol 1994; 13(12): 901–911.
48. Akhras, F, Dubrey, S, Gazzard, B, Noble MIM. Emerging patterns of
heart disease in HIV infected homosexual subjects with and without
opportunistic infections: a prospective color flow Doppler echocardio-
graphic study. Eur Heart J 1994; 15; 68–75.
49. Nair R, Robbs JV, Naidoo NG, Woolgar J. Clinical profile of HIV-related
aneurysms. Eur Vasc Endovasc Surg 2000; 20: 235–240.
50. Chetty R, Batitang S, Nair R. Large artery vasculopathy in HIV posi-
tive patients: another vasculitic enigma. Hum Path 2000; 31: 374–379.